July 05, 2016
The U.S. Patent and Trademark Office did not sufficiently extend the life of a patent related to treatments for diabetes after prolonging consideration of Takeda Pharmaceutical Co. Ltd.'s patent application, the drugmaker said in a recent Virginia federal lawsuit.